Latest Technology Commercialization News

Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.

Reward Minerals Limited is progressing its innovative potash processing technologies while simultaneously advancing exploration of its 100% owned Kalgoorlie gold projects, supported by a solid cash position of $1.738 million.

Latrobe Magnesium secures EPA licence extension and prepares to start magnesium oxide production in August, while pursuing a significant legal counterclaim and advancing commercial plant plans.

Aquirian Limited has secured $5 million in fresh capital to upgrade its Wubin emulsion facility and accelerate commercialization of its innovative Collar Keeper® technology, alongside a new $1.5 million tolling contract.

Neometals’ joint venture Reed Advanced Materials has signed a non-binding MoU with Rio Tinto to collaborate on advancing the ELi Process, a lithium hydroxide production technology promising significant cost and environmental benefits.

Hazer Group unveils a strategic alliance with engineering giant KBR to fast-track its low-cost clean hydrogen technology, targeting major global markets with a capex-lite licensing model.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Volt Group Limited reported a robust 26.8% revenue increase in Q1 FY25, driven by strong performances in its EcoQuip and Wescone divisions, alongside promising advances in its ATEN Waste Heat to Power technology.

Hiremii Limited has completed its 2024-25 AI recruitment platform roadmap nine weeks early, with its proprietary AI outperforming industry shortlisting benchmarks. Despite a slight revenue decline due to market slowdowns, the company is poised for growth through technology commercialization and strategic M&A.

De.mem Limited has delivered its second highest quarterly cash receipts ever alongside positive operating cash flow for the December 2024 quarter, marking a milestone full-year cash flow turnaround and setting the stage for continued growth in 2025.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.